

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.62196609 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 4.60923818 |
| 3 | response to peptidoglycan (GO:0032494) | 4.49991097 |
| 4 | negative regulation of interleukin-12 production (GO:0032695) | 4.00747414 |
| 5 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.93698170 |
| 6 | regulation of integrin activation (GO:0033623) | 3.86210077 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.62096084 |
| 8 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.59012980 |
| 9 | regulation of vitamin metabolic process (GO:0030656) | 3.51072027 |
| 10 | viral transcription (GO:0019083) | 3.37759731 |
| 11 | signal complex assembly (GO:0007172) | 3.37285460 |
| 12 | myeloid dendritic cell differentiation (GO:0043011) | 3.37045339 |
| 13 | regulation of early endosome to late endosome transport (GO:2000641) | 3.36864497 |
| 14 | erythrocyte maturation (GO:0043249) | 3.36087614 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.31123403 |
| 16 | germinal center formation (GO:0002467) | 3.27511269 |
| 17 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.23594041 |
| 18 | maternal placenta development (GO:0001893) | 3.23150296 |
| 19 | translational termination (GO:0006415) | 3.20548943 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.17816217 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.17816217 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.17816217 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.17816217 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.17816217 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.17816217 |
| 26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.14803838 |
| 27 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.13274183 |
| 28 | protein localization to endosome (GO:0036010) | 3.12427734 |
| 29 | establishment of apical/basal cell polarity (GO:0035089) | 3.11052918 |
| 30 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09959742 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.07832860 |
| 32 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.07517142 |
| 33 | mannose metabolic process (GO:0006013) | 3.07445461 |
| 34 | heterochromatin organization (GO:0070828) | 3.05761892 |
| 35 | regulation of chemokine biosynthetic process (GO:0045073) | 3.03267547 |
| 36 | apoptotic cell clearance (GO:0043277) | 3.01555575 |
| 37 | myeloid dendritic cell activation (GO:0001773) | 2.99824265 |
| 38 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.97323269 |
| 39 | response to protozoan (GO:0001562) | 2.96995655 |
| 40 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93564079 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 2.92333555 |
| 42 | regulation of mononuclear cell migration (GO:0071675) | 2.92106822 |
| 43 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.91806761 |
| 44 | positive regulation of histone deacetylation (GO:0031065) | 2.91116818 |
| 45 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90249322 |
| 46 | basement membrane organization (GO:0071711) | 2.88949133 |
| 47 | apoptotic process involved in morphogenesis (GO:0060561) | 2.88513953 |
| 48 | regulation of protein heterodimerization activity (GO:0043497) | 2.88129308 |
| 49 | monocyte chemotaxis (GO:0002548) | 2.87027472 |
| 50 | protein localization to kinetochore (GO:0034501) | 2.86250819 |
| 51 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.85576734 |
| 52 | cellular response to type I interferon (GO:0071357) | 2.85341647 |
| 53 | type I interferon signaling pathway (GO:0060337) | 2.85341647 |
| 54 | response to type I interferon (GO:0034340) | 2.84364512 |
| 55 | defense response to protozoan (GO:0042832) | 2.83550792 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82553755 |
| 57 | stress fiber assembly (GO:0043149) | 2.82245284 |
| 58 | modulation by symbiont of host cellular process (GO:0044068) | 2.79649882 |
| 59 | neutrophil activation involved in immune response (GO:0002283) | 2.79098683 |
| 60 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78907330 |
| 61 | response to laminar fluid shear stress (GO:0034616) | 2.78438252 |
| 62 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.76855098 |
| 63 | translational elongation (GO:0006414) | 2.75421008 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.75059912 |
| 65 | wound healing, spreading of epidermal cells (GO:0035313) | 2.74937199 |
| 66 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.73899603 |
| 67 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73851871 |
| 68 | mRNA stabilization (GO:0048255) | 2.73474940 |
| 69 | RNA stabilization (GO:0043489) | 2.73474940 |
| 70 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.71312202 |
| 71 | polarized epithelial cell differentiation (GO:0030859) | 2.69701077 |
| 72 | T cell migration (GO:0072678) | 2.69160605 |
| 73 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.67389448 |
| 74 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.67355469 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.67064006 |
| 76 | natural killer cell differentiation (GO:0001779) | 2.66917588 |
| 77 | leukocyte aggregation (GO:0070486) | 2.64160419 |
| 78 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.63809255 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.62908413 |
| 80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.62908413 |
| 81 | viral life cycle (GO:0019058) | 2.62226802 |
| 82 | regulation of interferon-alpha production (GO:0032647) | 2.62060001 |
| 83 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.61615598 |
| 84 | regulation of fever generation (GO:0031620) | 2.60424797 |
| 85 | T cell apoptotic process (GO:0070231) | 2.59977486 |
| 86 | positive regulation of heat generation (GO:0031652) | 2.59849611 |
| 87 | negative regulation of adherens junction organization (GO:1903392) | 2.59120182 |
| 88 | negative regulation of focal adhesion assembly (GO:0051895) | 2.59120182 |
| 89 | negative regulation of cell junction assembly (GO:1901889) | 2.59120182 |
| 90 | trophectodermal cell differentiation (GO:0001829) | 2.59093627 |
| 91 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58933909 |
| 92 | negative regulation of viral release from host cell (GO:1902187) | 2.57802944 |
| 93 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.57801162 |
| 94 | establishment of endothelial barrier (GO:0061028) | 2.57412974 |
| 95 | embryonic process involved in female pregnancy (GO:0060136) | 2.55019523 |
| 96 | cellular response to lipopolysaccharide (GO:0071222) | 2.55009122 |
| 97 | positive regulation of isotype switching (GO:0045830) | 2.54378427 |
| 98 | pinocytosis (GO:0006907) | 2.53486203 |
| 99 | necroptotic process (GO:0070266) | 2.53044021 |
| 100 | translational initiation (GO:0006413) | 2.52999303 |
| 101 | megakaryocyte development (GO:0035855) | 2.51331997 |
| 102 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.51300888 |
| 103 | cellular protein complex disassembly (GO:0043624) | 2.50754396 |
| 104 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.50310508 |
| 105 | morphogenesis of an endothelium (GO:0003159) | 2.49936255 |
| 106 | endothelial tube morphogenesis (GO:0061154) | 2.49936255 |
| 107 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.48557885 |
| 108 | establishment of monopolar cell polarity (GO:0061162) | 2.48557885 |
| 109 | T-helper 1 type immune response (GO:0042088) | 2.47883929 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47514407 |
| 111 | positive regulation of lamellipodium assembly (GO:0010592) | 2.47285925 |
| 112 | macrophage activation involved in immune response (GO:0002281) | 2.46573832 |
| 113 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.46120972 |
| 114 | regulation of necroptotic process (GO:0060544) | 2.45499568 |
| 115 | mRNA transcription (GO:0009299) | 2.44893245 |
| 116 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.44642907 |
| 117 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.43880230 |
| 118 | cellular response to molecule of bacterial origin (GO:0071219) | 2.42892800 |
| 119 | regulation of lymphocyte migration (GO:2000401) | 2.42826904 |
| 120 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.41505933 |
| 121 | positive regulation of B cell mediated immunity (GO:0002714) | 2.41147882 |
| 122 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.41147882 |
| 123 | immunoglobulin mediated immune response (GO:0016064) | 2.40743187 |
| 124 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.40615214 |
| 125 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.39738187 |
| 126 | cellular response to arsenic-containing substance (GO:0071243) | 2.39521459 |
| 127 | regulation of necrotic cell death (GO:0010939) | 2.39494554 |
| 128 | regulation of type 2 immune response (GO:0002828) | 2.38254810 |
| 129 | regulation of gene silencing by RNA (GO:0060966) | 2.37682500 |
| 130 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.37682500 |
| 131 | regulation of gene silencing by miRNA (GO:0060964) | 2.37682500 |
| 132 | adherens junction assembly (GO:0034333) | 2.37563055 |
| 133 | protein targeting to ER (GO:0045047) | 2.37071964 |
| 134 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.36458887 |
| 135 | mitotic sister chromatid segregation (GO:0000070) | 2.36449745 |
| 136 | DNA unwinding involved in DNA replication (GO:0006268) | 2.36148695 |
| 137 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.36016818 |
| 138 | barbed-end actin filament capping (GO:0051016) | 2.35794400 |
| 139 | cellular extravasation (GO:0045123) | 2.35602256 |
| 140 | positive regulation of interferon-alpha production (GO:0032727) | 2.35080850 |
| 141 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.34700380 |
| 142 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.34698932 |
| 143 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.34641928 |
| 144 | positive thymic T cell selection (GO:0045059) | 2.34564769 |
| 145 | positive regulation of protein homooligomerization (GO:0032464) | 2.34518860 |
| 146 | cortical actin cytoskeleton organization (GO:0030866) | 2.33915788 |
| 147 | protein heterotrimerization (GO:0070208) | 2.33615642 |
| 148 | chromatin assembly (GO:0031497) | 2.33534590 |
| 149 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.33242198 |
| 150 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.33102394 |
| 151 | protein complex disassembly (GO:0043241) | 2.33065191 |
| 152 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.32001906 |
| 153 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.31639409 |
| 154 | regulation of chronic inflammatory response (GO:0002676) | 2.31605611 |
| 155 | regulation of translational termination (GO:0006449) | 2.31423962 |
| 156 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.30873069 |
| 157 | lymphocyte chemotaxis (GO:0048247) | 2.30783499 |
| 158 | cellular senescence (GO:0090398) | 2.29495970 |
| 159 | regulation of macrophage cytokine production (GO:0010935) | 2.29194642 |
| 160 | cotranslational protein targeting to membrane (GO:0006613) | 2.29096729 |
| 161 | protein localization to chromosome, centromeric region (GO:0071459) | 2.28530820 |
| 162 | sister chromatid segregation (GO:0000819) | 2.27312950 |
| 163 | negative regulation of fatty acid transport (GO:2000192) | 2.26326508 |
| 164 | regulation of translational fidelity (GO:0006450) | 2.26255380 |
| 165 | regulation of podosome assembly (GO:0071801) | 2.25898371 |
| 166 | positive regulation of nuclease activity (GO:0032075) | 2.24805634 |
| 167 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.24682851 |
| 168 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.24480419 |
| 169 | positive regulation of protein deacetylation (GO:0090312) | 2.23085076 |
| 170 | endodermal cell differentiation (GO:0035987) | 2.22857283 |
| 171 | cell-substrate junction assembly (GO:0007044) | 2.20837892 |
| 172 | regulation of erythrocyte differentiation (GO:0045646) | 2.20794588 |
| 173 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.19910463 |
| 174 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.19686086 |
| 175 | negative regulation of glial cell proliferation (GO:0060253) | 2.19616569 |
| 176 | B cell mediated immunity (GO:0019724) | 2.19439706 |
| 177 | activation of MAPKKK activity (GO:0000185) | 2.19407192 |
| 178 | negative regulation of cell size (GO:0045792) | 2.18632504 |
| 179 | lymphocyte apoptotic process (GO:0070227) | 2.18058893 |
| 180 | cellular hyperosmotic response (GO:0071474) | 2.18037210 |
| 181 | regulation of p38MAPK cascade (GO:1900744) | 2.16440759 |
| 182 | nodal signaling pathway (GO:0038092) | 2.16255152 |
| 183 | pre-miRNA processing (GO:0031054) | 2.16200270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.13109468 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.73419129 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.49878744 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.44666904 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.13907115 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.72253430 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68685415 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44567528 |
| 9 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.41936681 |
| 10 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.28939619 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.25140952 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.18716194 |
| 13 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.11841933 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.03626129 |
| 15 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83699382 |
| 16 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.80723766 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80676740 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76881475 |
| 19 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74404422 |
| 20 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.71543150 |
| 21 | * MAF_26560356_Chip-Seq_TH1_Human | 1.71058262 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69942445 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69813874 |
| 24 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.69778397 |
| 25 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.68831408 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67750757 |
| 27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67721397 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67688955 |
| 29 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66319118 |
| 30 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.64205950 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.60648321 |
| 32 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.60084225 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59286880 |
| 34 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.58496457 |
| 35 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.52316614 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51751904 |
| 37 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51117153 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50895599 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50199506 |
| 40 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49172631 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46984013 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45367932 |
| 43 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.45065304 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44481379 |
| 45 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.43861273 |
| 46 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.43246509 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43041981 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42369713 |
| 49 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.42288032 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40821883 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40119268 |
| 52 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39749197 |
| 53 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39749197 |
| 54 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.39749197 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.38968485 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37336903 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36504524 |
| 58 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35931027 |
| 59 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34641488 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33898948 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32691046 |
| 62 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.32437041 |
| 63 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32422310 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31356717 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31274572 |
| 66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31007949 |
| 67 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.30021141 |
| 68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29845622 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29112876 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27981590 |
| 71 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.25915965 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25619425 |
| 73 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25148656 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24472930 |
| 75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24419853 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24074556 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22417761 |
| 78 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22006725 |
| 79 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21512607 |
| 80 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21326493 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20451164 |
| 82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17707446 |
| 83 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.16344324 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15753015 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14572211 |
| 86 | * MAF_26560356_Chip-Seq_TH2_Human | 1.14431187 |
| 87 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13141950 |
| 88 | * MYB_26560356_Chip-Seq_TH1_Human | 1.12284761 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11895107 |
| 90 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11644919 |
| 91 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.11562826 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10525067 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09906564 |
| 94 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09420786 |
| 95 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08779570 |
| 96 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07522423 |
| 97 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07155414 |
| 98 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07030764 |
| 99 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06783114 |
| 100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06703053 |
| 101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06539562 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06521352 |
| 103 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05383250 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05308705 |
| 105 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05148874 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05059008 |
| 107 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04398650 |
| 108 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04070009 |
| 109 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03315276 |
| 110 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02952627 |
| 111 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02406115 |
| 112 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01923092 |
| 113 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01915769 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01850924 |
| 115 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.01710219 |
| 116 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00853167 |
| 117 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00587672 |
| 118 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.99347055 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99306507 |
| 120 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99168180 |
| 121 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98819347 |
| 122 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.98319318 |
| 123 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97657700 |
| 124 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.97196612 |
| 125 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97139106 |
| 126 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97059029 |
| 127 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.96768223 |
| 128 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.96598845 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96526007 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95865737 |
| 131 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95572484 |
| 132 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95309156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.23488629 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.78145412 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 2.98238242 |
| 4 | MP0005076_abnormal_cell_differentiation | 2.97417383 |
| 5 | MP0009278_abnormal_bone_marrow | 2.69700891 |
| 6 | MP0009840_abnormal_foam_cell | 2.60445582 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.59372104 |
| 8 | MP0009785_altered_susceptibility_to | 2.41594931 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.40728155 |
| 10 | MP0003566_abnormal_cell_adhesion | 2.33001931 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.27231118 |
| 12 | MP0005671_abnormal_response_to | 2.27187597 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.27045172 |
| 14 | MP0005451_abnormal_body_composition | 2.21198822 |
| 15 | MP0004272_abnormal_basement_membrane | 2.08823758 |
| 16 | MP0006054_spinal_hemorrhage | 2.01095829 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.00110506 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 2.00110506 |
| 19 | MP0003828_pulmonary_edema | 1.95583321 |
| 20 | MP0002254_reproductive_system_inflammat | 1.92202011 |
| 21 | MP0010307_abnormal_tumor_latency | 1.90859262 |
| 22 | MP0001853_heart_inflammation | 1.87300036 |
| 23 | MP0003436_decreased_susceptibility_to | 1.81451202 |
| 24 | MP0004510_myositis | 1.71845512 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.68911991 |
| 26 | MP0000490_abnormal_crypts_of | 1.67457049 |
| 27 | MP0004957_abnormal_blastocyst_morpholog | 1.62150516 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.59804790 |
| 29 | MP0003091_abnormal_cell_migration | 1.58938415 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.57443820 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.56282576 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.54626953 |
| 33 | MP0000685_abnormal_immune_system | 1.53648961 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.51818020 |
| 35 | MP0005623_abnormal_meninges_morphology | 1.49294687 |
| 36 | MP0003448_altered_tumor_morphology | 1.45534618 |
| 37 | MP0003279_aneurysm | 1.45487282 |
| 38 | MP0003111_abnormal_nucleus_morphology | 1.45369861 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.45040850 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.44820587 |
| 41 | MP0003693_abnormal_embryo_hatching | 1.43798712 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.43699272 |
| 43 | MP0005310_abnormal_salivary_gland | 1.40737318 |
| 44 | MP0005023_abnormal_wound_healing | 1.40494922 |
| 45 | MP0002086_abnormal_extraembryonic_tissu | 1.37165661 |
| 46 | MP0000350_abnormal_cell_proliferation | 1.34597743 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.31784077 |
| 48 | MP0004858_abnormal_nervous_system | 1.31734661 |
| 49 | MP0009764_decreased_sensitivity_to | 1.30083513 |
| 50 | MP0000858_altered_metastatic_potential | 1.29619880 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.28869148 |
| 52 | MP0001730_embryonic_growth_arrest | 1.24739161 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.24202225 |
| 54 | MP0001879_abnormal_lymphatic_vessel | 1.21473002 |
| 55 | MP0002405_respiratory_system_inflammati | 1.20977817 |
| 56 | MP0008961_abnormal_basal_metabolism | 1.20067790 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.19294259 |
| 58 | MP0000767_abnormal_smooth_muscle | 1.19028106 |
| 59 | MP0006082_CNS_inflammation | 1.18250124 |
| 60 | MP0000733_abnormal_muscle_development | 1.16918313 |
| 61 | MP0002452_abnormal_antigen_presenting | 1.15904697 |
| 62 | MP0003453_abnormal_keratinocyte_physiol | 1.15459853 |
| 63 | MP0001915_intracranial_hemorrhage | 1.15262134 |
| 64 | MP0004947_skin_inflammation | 1.14455725 |
| 65 | MP0001873_stomach_inflammation | 1.14348499 |
| 66 | MP0002398_abnormal_bone_marrow | 1.13983495 |
| 67 | MP0003984_embryonic_growth_retardation | 1.11974014 |
| 68 | MP0005000_abnormal_immune_tolerance | 1.11193814 |
| 69 | MP0002088_abnormal_embryonic_growth/wei | 1.10982257 |
| 70 | MP0008469_abnormal_protein_level | 1.09866049 |
| 71 | MP0003077_abnormal_cell_cycle | 1.07598413 |
| 72 | MP0001697_abnormal_embryo_size | 1.06733135 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.06255865 |
| 74 | MP0010030_abnormal_orbit_morphology | 1.06101693 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.05948727 |
| 76 | MP0001672_abnormal_embryogenesis/_devel | 1.05264330 |
| 77 | MP0005380_embryogenesis_phenotype | 1.05264330 |
| 78 | MP0003866_abnormal_defecation | 1.05002926 |
| 79 | MP0002925_abnormal_cardiovascular_devel | 1.04557965 |
| 80 | MP0005257_abnormal_intraocular_pressure | 1.04130728 |
| 81 | MP0002396_abnormal_hematopoietic_system | 1.03805365 |
| 82 | MP0001849_ear_inflammation | 1.03250981 |
| 83 | MP0001800_abnormal_humoral_immune | 1.02356846 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.01661016 |
| 85 | MP0008260_abnormal_autophagy | 1.01656117 |
| 86 | MP0002138_abnormal_hepatobiliary_system | 1.01449566 |
| 87 | MP0002722_abnormal_immune_system | 1.00170066 |
| 88 | MP0005387_immune_system_phenotype | 0.99638813 |
| 89 | MP0001790_abnormal_immune_system | 0.99638813 |
| 90 | MP0000689_abnormal_spleen_morphology | 0.98759691 |
| 91 | MP0003075_altered_response_to | 0.97675400 |
| 92 | MP0004197_abnormal_fetal_growth/weight/ | 0.97605506 |
| 93 | MP0001819_abnormal_immune_cell | 0.95947957 |
| 94 | MP0000604_amyloidosis | 0.95886279 |
| 95 | MP0004381_abnormal_hair_follicle | 0.95173413 |
| 96 | MP0002420_abnormal_adaptive_immunity | 0.95140392 |
| 97 | MP0001958_emphysema | 0.94134352 |
| 98 | MP0002080_prenatal_lethality | 0.93805695 |
| 99 | MP0005025_abnormal_response_to | 0.92933103 |
| 100 | MP0002084_abnormal_developmental_patter | 0.92090825 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.91497511 |
| 102 | MP0002085_abnormal_embryonic_tissue | 0.90901893 |
| 103 | MP0003724_increased_susceptibility_to | 0.90135050 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.89718881 |
| 105 | MP0002419_abnormal_innate_immunity | 0.89698368 |
| 106 | MP0002429_abnormal_blood_cell | 0.89383176 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.87499022 |
| 108 | MP0000343_altered_response_to | 0.87306582 |
| 109 | MP0002796_impaired_skin_barrier | 0.87280525 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85919233 |
| 111 | MP0002723_abnormal_immune_serum | 0.85851828 |
| 112 | MP0003045_fibrosis | 0.85227238 |
| 113 | MP0001348_abnormal_lacrimal_gland | 0.84044367 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.83744990 |
| 115 | MP0002933_joint_inflammation | 0.83688076 |
| 116 | MP0005166_decreased_susceptibility_to | 0.83675186 |
| 117 | MP0000716_abnormal_immune_system | 0.82664608 |
| 118 | MP0000313_abnormal_cell_death | 0.82557776 |
| 119 | MP0010630_abnormal_cardiac_muscle | 0.81927188 |
| 120 | MP0005390_skeleton_phenotype | 0.81683655 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.80960499 |
| 122 | MP0008004_abnormal_stomach_pH | 0.80528957 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.80393895 |
| 124 | MP0001663_abnormal_digestive_system | 0.80145835 |
| 125 | MP0002139_abnormal_hepatobiliary_system | 0.80088000 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.79555341 |
| 127 | MP0003123_paternal_imprinting | 0.79475588 |
| 128 | MP0002089_abnormal_postnatal_growth/wei | 0.75862802 |
| 129 | MP0001851_eye_inflammation | 0.74595482 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.73054238 |
| 131 | MP0000249_abnormal_blood_vessel | 0.72818989 |
| 132 | MP0002006_tumorigenesis | 0.72269948 |
| 133 | MP0003795_abnormal_bone_structure | 0.69677298 |
| 134 | MP0001542_abnormal_bone_strength | 0.65275779 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.62839012 |
| 136 | MP0005164_abnormal_response_to | 0.62520311 |
| 137 | MP0004883_abnormal_blood_vessel | 0.61812364 |
| 138 | MP0005381_digestive/alimentary_phenotyp | 0.61631283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 4.62809227 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.45818765 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.45818765 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.45818765 |
| 5 | Protrusio acetabuli (HP:0003179) | 4.07348748 |
| 6 | Orchitis (HP:0100796) | 3.82652816 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 3.67255617 |
| 8 | Optic neuritis (HP:0100653) | 3.67255617 |
| 9 | Premature rupture of membranes (HP:0001788) | 3.63843230 |
| 10 | Nuclear cataract (HP:0100018) | 3.38797174 |
| 11 | Myositis (HP:0100614) | 3.37479333 |
| 12 | Cellulitis (HP:0100658) | 3.08623839 |
| 13 | Loss of speech (HP:0002371) | 3.04896617 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04114481 |
| 15 | Genu recurvatum (HP:0002816) | 3.01642410 |
| 16 | Dysostosis multiplex (HP:0000943) | 2.94704469 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 2.81577036 |
| 18 | Ulnar bowing (HP:0003031) | 2.81510447 |
| 19 | Shallow orbits (HP:0000586) | 2.65023651 |
| 20 | Keratoconjunctivitis sicca (HP:0001097) | 2.63421872 |
| 21 | Achilles tendon contracture (HP:0001771) | 2.58220073 |
| 22 | Mitral valve prolapse (HP:0001634) | 2.57894070 |
| 23 | Stomatitis (HP:0010280) | 2.54938788 |
| 24 | Ankle contracture (HP:0006466) | 2.53929096 |
| 25 | Hematochezia (HP:0002573) | 2.52455458 |
| 26 | Axonal loss (HP:0003447) | 2.47882345 |
| 27 | Dilatation of the ascending aorta (HP:0005111) | 2.46960398 |
| 28 | Increased density of long bones (HP:0006392) | 2.44677727 |
| 29 | Spontaneous hematomas (HP:0007420) | 2.41531222 |
| 30 | Recurrent viral infections (HP:0004429) | 2.41146149 |
| 31 | Hypercortisolism (HP:0001578) | 2.40266662 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.39796542 |
| 33 | Polycythemia (HP:0001901) | 2.38925565 |
| 34 | Meningitis (HP:0001287) | 2.38074534 |
| 35 | Gastrointestinal stroma tumor (HP:0100723) | 2.33739436 |
| 36 | Annular pancreas (HP:0001734) | 2.32691974 |
| 37 | Vasculitis (HP:0002633) | 2.32342269 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.31342888 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.30718456 |
| 40 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.29283280 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27972480 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27972480 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27972480 |
| 44 | Rectal prolapse (HP:0002035) | 2.26906645 |
| 45 | Slow saccadic eye movements (HP:0000514) | 2.24361125 |
| 46 | Peritonitis (HP:0002586) | 2.22326499 |
| 47 | Pulmonary infiltrates (HP:0002113) | 2.19953138 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.19419163 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.17644491 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.17644491 |
| 51 | Pustule (HP:0200039) | 2.15052515 |
| 52 | Increased connective tissue (HP:0009025) | 2.13680893 |
| 53 | Mucopolysacchariduria (HP:0008155) | 2.12375624 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12375624 |
| 55 | Disinhibition (HP:0000734) | 2.11869092 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11837054 |
| 57 | Obstructive lung disease (HP:0006536) | 2.11837054 |
| 58 | Arterial thrombosis (HP:0004420) | 2.11003334 |
| 59 | Cervical subluxation (HP:0003308) | 2.10551060 |
| 60 | Tetraparesis (HP:0002273) | 2.10124500 |
| 61 | Reticulocytosis (HP:0001923) | 2.10011108 |
| 62 | Porencephaly (HP:0002132) | 2.09431592 |
| 63 | Fragile skin (HP:0001030) | 2.08968603 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.08878807 |
| 65 | Hand muscle atrophy (HP:0009130) | 2.07402279 |
| 66 | Hemorrhage of the eye (HP:0011885) | 2.06519419 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.05562555 |
| 68 | Aortic dissection (HP:0002647) | 2.04720268 |
| 69 | Aortic aneurysm (HP:0004942) | 2.04419120 |
| 70 | Vertebral compression fractures (HP:0002953) | 2.00731769 |
| 71 | Verrucae (HP:0200043) | 2.00589833 |
| 72 | Papilloma (HP:0012740) | 2.00589833 |
| 73 | Pathologic fracture (HP:0002756) | 1.99779622 |
| 74 | Recurrent skin infections (HP:0001581) | 1.99615699 |
| 75 | Increased serum ferritin (HP:0003281) | 1.99552884 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98836696 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98523363 |
| 78 | Increased IgE level (HP:0003212) | 1.98369988 |
| 79 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.97998192 |
| 80 | Trismus (HP:0000211) | 1.97100643 |
| 81 | Hemoptysis (HP:0002105) | 1.97080116 |
| 82 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.97045748 |
| 83 | Apathy (HP:0000741) | 1.96352624 |
| 84 | Hyperacusis (HP:0010780) | 1.95188139 |
| 85 | Neuronal loss in central nervous system (HP:0002529) | 1.94027342 |
| 86 | Malnutrition (HP:0004395) | 1.94000781 |
| 87 | Recurrent fungal infections (HP:0002841) | 1.93869042 |
| 88 | Neurofibrillary tangles (HP:0002185) | 1.92051260 |
| 89 | Aneurysm (HP:0002617) | 1.90328602 |
| 90 | Basal cell carcinoma (HP:0002671) | 1.89172613 |
| 91 | Progressive neurologic deterioration (HP:0002344) | 1.89003903 |
| 92 | Atrophic scars (HP:0001075) | 1.87767962 |
| 93 | Premature loss of primary teeth (HP:0006323) | 1.85858977 |
| 94 | Emphysema (HP:0002097) | 1.84530781 |
| 95 | Diminished motivation (HP:0000745) | 1.83576852 |
| 96 | Bowed forearm bones (HP:0003956) | 1.83193580 |
| 97 | Bowing of the arm (HP:0006488) | 1.83193580 |
| 98 | Bone pain (HP:0002653) | 1.81527355 |
| 99 | Restrictive lung disease (HP:0002091) | 1.80612285 |
| 100 | Esophageal varix (HP:0002040) | 1.80226911 |
| 101 | Multiple enchondromatosis (HP:0005701) | 1.80141327 |
| 102 | Encephalitis (HP:0002383) | 1.79745678 |
| 103 | Colitis (HP:0002583) | 1.78406522 |
| 104 | J-shaped sella turcica (HP:0002680) | 1.77636152 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 1.77084510 |
| 106 | Long palpebral fissure (HP:0000637) | 1.76861685 |
| 107 | Increased IgM level (HP:0003496) | 1.75927133 |
| 108 | Distal lower limb amyotrophy (HP:0008944) | 1.75000787 |
| 109 | Bulbar palsy (HP:0001283) | 1.74939218 |
| 110 | Radial bowing (HP:0002986) | 1.74929608 |
| 111 | Purpura (HP:0000979) | 1.74645668 |
| 112 | Increased cerebral lipofuscin (HP:0011813) | 1.74056399 |
| 113 | Cerebral inclusion bodies (HP:0100314) | 1.73881032 |
| 114 | High pitched voice (HP:0001620) | 1.73738470 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 1.73054993 |
| 116 | Difficulty climbing stairs (HP:0003551) | 1.72911507 |
| 117 | Abnormality of reticulocytes (HP:0004312) | 1.72733650 |
| 118 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71876924 |
| 119 | Multiple lipomas (HP:0001012) | 1.71011960 |
| 120 | Diaphragmatic weakness (HP:0009113) | 1.70998648 |
| 121 | Pulmonary embolism (HP:0002204) | 1.70542079 |
| 122 | Amyloidosis (HP:0011034) | 1.70042522 |
| 123 | Progressive sensorineural hearing impairment (HP:0000408) | 1.69864291 |
| 124 | Bicuspid aortic valve (HP:0001647) | 1.69642387 |
| 125 | Bladder diverticulum (HP:0000015) | 1.69439760 |
| 126 | Gingivitis (HP:0000230) | 1.68689193 |
| 127 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.68658020 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.68589225 |
| 129 | Ankyloglossia (HP:0010296) | 1.68390402 |
| 130 | Aseptic necrosis (HP:0010885) | 1.68185721 |
| 131 | Acrocyanosis (HP:0001063) | 1.68029409 |
| 132 | Abnormality of the peritoneum (HP:0002585) | 1.68016399 |
| 133 | Angiofibromas (HP:0010615) | 1.67464719 |
| 134 | Adenoma sebaceum (HP:0009720) | 1.67464719 |
| 135 | Blue sclerae (HP:0000592) | 1.67445685 |
| 136 | Glomerulonephritis (HP:0000099) | 1.67258857 |
| 137 | Lymphopenia (HP:0001888) | 1.67067281 |
| 138 | Mitral regurgitation (HP:0001653) | 1.65945409 |
| 139 | Polygenic inheritance (HP:0010982) | 1.65695017 |
| 140 | Abnormal hemoglobin (HP:0011902) | 1.65460288 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65289644 |
| 142 | Osteolytic defects of the hand bones (HP:0009699) | 1.65289644 |
| 143 | Gastrointestinal infarctions (HP:0005244) | 1.63975654 |
| 144 | Hyperparathyroidism (HP:0000843) | 1.62181483 |
| 145 | Thoracic kyphosis (HP:0002942) | 1.61648480 |
| 146 | Thoracolumbar scoliosis (HP:0002944) | 1.61414122 |
| 147 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.61244899 |
| 148 | Abnormal vertebral ossification (HP:0100569) | 1.61199320 |
| 149 | Recurrent bacterial skin infections (HP:0005406) | 1.61162432 |
| 150 | Peripheral demyelination (HP:0011096) | 1.61157377 |
| 151 | Abnormality of macrophages (HP:0004311) | 1.60454015 |
| 152 | Subacute progressive viral hepatitis (HP:0006572) | 1.60377156 |
| 153 | Disproportionate tall stature (HP:0001519) | 1.60182555 |
| 154 | IgA deficiency (HP:0002720) | 1.59994699 |
| 155 | Abnormality of the acetabulum (HP:0003170) | 1.59695658 |
| 156 | Myocardial infarction (HP:0001658) | 1.59627842 |
| 157 | Enlarged penis (HP:0000040) | 1.59514119 |
| 158 | Renal duplication (HP:0000075) | 1.59245017 |
| 159 | Broad palm (HP:0001169) | 1.58416446 |
| 160 | Abnormal number of erythroid precursors (HP:0012131) | 1.58343816 |
| 161 | Hypochromic anemia (HP:0001931) | 1.56428943 |
| 162 | Mediastinal lymphadenopathy (HP:0100721) | 1.56410529 |
| 163 | Wrist flexion contracture (HP:0001239) | 1.56284043 |
| 164 | Gastrointestinal carcinoma (HP:0002672) | 1.55747720 |
| 165 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.55747720 |
| 166 | Hyperextensible skin (HP:0000974) | 1.54865836 |
| 167 | Hallux valgus (HP:0001822) | 1.54331782 |
| 168 | Pointed chin (HP:0000307) | 1.54252540 |
| 169 | Vertebral hypoplasia (HP:0008417) | 1.53527663 |
| 170 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.53527663 |
| 171 | Deviation of the hallux (HP:0010051) | 1.53493799 |
| 172 | Fibroma (HP:0010614) | 1.53483131 |
| 173 | Camptodactyly of toe (HP:0001836) | 1.53256610 |
| 174 | Insomnia (HP:0100785) | 1.53238675 |
| 175 | Thin bony cortex (HP:0002753) | 1.52118000 |
| 176 | Bowel diverticulosis (HP:0005222) | 1.51709330 |
| 177 | Slender build (HP:0001533) | 1.50810146 |
| 178 | Abnormal platelet volume (HP:0011876) | 1.50345448 |
| 179 | Persistence of primary teeth (HP:0006335) | 1.49758823 |
| 180 | Spinal muscular atrophy (HP:0007269) | 1.49324797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.03883795 |
| 2 | MAP3K10 | 3.99570505 |
| 3 | TRIB3 | 3.97829583 |
| 4 | PRPF4B | 3.39019067 |
| 5 | PKN2 | 3.35185896 |
| 6 | EEF2K | 3.03261579 |
| 7 | ERN1 | 2.99344509 |
| 8 | RIPK1 | 2.45922476 |
| 9 | SMG1 | 2.44064373 |
| 10 | CDK12 | 2.38950252 |
| 11 | SIK1 | 2.36780543 |
| 12 | MAP3K14 | 2.24342521 |
| 13 | TAOK2 | 2.14474912 |
| 14 | IRAK4 | 1.86242233 |
| 15 | BMX | 1.84590026 |
| 16 | MAP4K1 | 1.82878068 |
| 17 | PIM2 | 1.81983082 |
| 18 | PDGFRA | 1.75191371 |
| 19 | SCYL2 | 1.72377070 |
| 20 | NME2 | 1.72115288 |
| 21 | NEK2 | 1.61866273 |
| 22 | STK10 | 1.60810826 |
| 23 | MAP3K11 | 1.59617449 |
| 24 | DDR2 | 1.57192510 |
| 25 | LRRK2 | 1.56634915 |
| 26 | IRAK2 | 1.52625737 |
| 27 | TLK1 | 1.47674416 |
| 28 | ALK | 1.46613644 |
| 29 | PAK4 | 1.42128084 |
| 30 | MAP3K13 | 1.41217731 |
| 31 | SIK3 | 1.39395639 |
| 32 | TAOK1 | 1.36951795 |
| 33 | RIPK4 | 1.36635610 |
| 34 | PTK6 | 1.36337335 |
| 35 | MATK | 1.36025764 |
| 36 | GRK6 | 1.34799721 |
| 37 | ICK | 1.32187302 |
| 38 | TBK1 | 1.25394703 |
| 39 | CSK | 1.25336850 |
| 40 | KSR2 | 1.21872284 |
| 41 | MAP3K8 | 1.17406610 |
| 42 | MOS | 1.15704960 |
| 43 | FGFR4 | 1.14892940 |
| 44 | IKBKE | 1.13045895 |
| 45 | CHUK | 1.11708559 |
| 46 | RPS6KA4 | 1.11023321 |
| 47 | CDC42BPA | 1.07999779 |
| 48 | TGFBR2 | 1.05682462 |
| 49 | PIM1 | 1.05357196 |
| 50 | IRAK1 | 1.05019811 |
| 51 | SIK2 | 1.04605306 |
| 52 | CDK6 | 1.03670402 |
| 53 | PRKG2 | 1.00659635 |
| 54 | EPHA2 | 1.00394794 |
| 55 | DMPK | 1.00344109 |
| 56 | STK24 | 0.99194002 |
| 57 | KDR | 0.96936272 |
| 58 | FGR | 0.96220872 |
| 59 | TTN | 0.95133330 |
| 60 | RPS6KB2 | 0.91828490 |
| 61 | LATS2 | 0.91570900 |
| 62 | MAP2K3 | 0.91532736 |
| 63 | TYRO3 | 0.90261951 |
| 64 | PDPK1 | 0.88913175 |
| 65 | STK4 | 0.88019682 |
| 66 | GRK7 | 0.85139612 |
| 67 | DAPK3 | 0.83888878 |
| 68 | BLK | 0.82042028 |
| 69 | CDK7 | 0.81711137 |
| 70 | ARAF | 0.81502843 |
| 71 | PTK2 | 0.79857074 |
| 72 | CDK4 | 0.79301544 |
| 73 | RET | 0.77957272 |
| 74 | FES | 0.77456955 |
| 75 | FLT3 | 0.77258774 |
| 76 | MAP2K2 | 0.75582353 |
| 77 | TIE1 | 0.72473625 |
| 78 | MTOR | 0.70876475 |
| 79 | DYRK1B | 0.70609643 |
| 80 | EPHB1 | 0.70274032 |
| 81 | TRPM7 | 0.69234093 |
| 82 | MAP3K9 | 0.68657675 |
| 83 | EPHB2 | 0.67706463 |
| 84 | PAK2 | 0.66685651 |
| 85 | STK3 | 0.66405640 |
| 86 | MAPKAPK3 | 0.64829802 |
| 87 | PTK2B | 0.60920194 |
| 88 | ZAP70 | 0.60516644 |
| 89 | WEE1 | 0.60041921 |
| 90 | MARK3 | 0.59819069 |
| 91 | RPS6KC1 | 0.59492445 |
| 92 | RPS6KL1 | 0.59492445 |
| 93 | HCK | 0.59439316 |
| 94 | CDC7 | 0.58083479 |
| 95 | TESK1 | 0.58031758 |
| 96 | TESK2 | 0.58021313 |
| 97 | NTRK1 | 0.57092284 |
| 98 | TYK2 | 0.56575319 |
| 99 | RPS6KA6 | 0.56326462 |
| 100 | MAPK11 | 0.55817647 |
| 101 | RPS6KA1 | 0.52827881 |
| 102 | PAK1 | 0.50953752 |
| 103 | BTK | 0.50574052 |
| 104 | BRAF | 0.49001765 |
| 105 | GRK5 | 0.48618853 |
| 106 | ILK | 0.48544620 |
| 107 | MAPK4 | 0.47938259 |
| 108 | EGFR | 0.47538908 |
| 109 | IKBKB | 0.47162496 |
| 110 | JAK1 | 0.45890946 |
| 111 | PDGFRB | 0.45878846 |
| 112 | TAF1 | 0.45427730 |
| 113 | MAPKAPK2 | 0.45396658 |
| 114 | RPS6KA2 | 0.45239189 |
| 115 | MAP2K6 | 0.44906152 |
| 116 | DAPK2 | 0.44634376 |
| 117 | CAMKK1 | 0.44474188 |
| 118 | HIPK2 | 0.44418377 |
| 119 | MAP3K3 | 0.44278649 |
| 120 | CDK9 | 0.44221443 |
| 121 | JAK2 | 0.43328845 |
| 122 | NEK9 | 0.42124620 |
| 123 | NEK1 | 0.41414242 |
| 124 | MARK2 | 0.41178714 |
| 125 | LYN | 0.41133533 |
| 126 | PDK1 | 0.40288629 |
| 127 | MAP2K1 | 0.40258304 |
| 128 | PRKD2 | 0.40026389 |
| 129 | CLK1 | 0.39642179 |
| 130 | BMPR2 | 0.38931284 |
| 131 | MAP3K1 | 0.38707615 |
| 132 | LCK | 0.38195857 |
| 133 | JAK3 | 0.37698102 |
| 134 | CSF1R | 0.36215720 |
| 135 | MAPK7 | 0.36046639 |
| 136 | YES1 | 0.35561385 |
| 137 | ABL2 | 0.32887696 |
| 138 | PRKCI | 0.31172384 |
| 139 | ITK | 0.30827780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14625938 |
| 2 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.94199204 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 1.92542733 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.86188315 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83726554 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76875219 |
| 7 | Bladder cancer_Homo sapiens_hsa05219 | 1.74938584 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70294560 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69844476 |
| 10 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.64837700 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60386921 |
| 12 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.57173315 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52678504 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.50343544 |
| 15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.49947920 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48777391 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45199799 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44728340 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44235146 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.43273240 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42906778 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.42818787 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.39873928 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.37481468 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.32415786 |
| 26 | Apoptosis_Homo sapiens_hsa04210 | 1.31292787 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.29655138 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29499663 |
| 29 | Amoebiasis_Homo sapiens_hsa05146 | 1.27814582 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26198641 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24241611 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23607175 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.23574738 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.22136772 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.20814511 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.20168810 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18849529 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18593269 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.18286458 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18250748 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17731223 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.17429806 |
| 43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.17251792 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.17173753 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.15067096 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 1.15030664 |
| 47 | Adherens junction_Homo sapiens_hsa04520 | 1.14938566 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.14810902 |
| 49 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.13469405 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11979220 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10897832 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10209035 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09588516 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09309874 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.08733305 |
| 56 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08474969 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08072537 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.05823064 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04032374 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00132817 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.99118074 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.98575367 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.98444057 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.97822676 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95921485 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95419182 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94294518 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.94106917 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93579103 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.91911954 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91837209 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91785197 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90010416 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89122184 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.88697529 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.86722564 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86683861 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86434918 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.86095003 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82895853 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82498389 |
| 82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.82319032 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82095104 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.82024089 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.81442055 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81199471 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80813740 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79941638 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.79116501 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78906260 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78560373 |
| 92 | Phagosome_Homo sapiens_hsa04145 | 0.78532304 |
| 93 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78169773 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.77748705 |
| 95 | Measles_Homo sapiens_hsa05162 | 0.76066800 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75861662 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75813718 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.75543380 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74445449 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73473734 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73147745 |
| 102 | Prostate cancer_Homo sapiens_hsa05215 | 0.72509896 |
| 103 | Alcoholism_Homo sapiens_hsa05034 | 0.70934677 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70509395 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68420335 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67747739 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67546952 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66552284 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65779767 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65545263 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.63539587 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.63415509 |
| 113 | RNA transport_Homo sapiens_hsa03013 | 0.62904233 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62554169 |
| 115 | Mismatch repair_Homo sapiens_hsa03430 | 0.61448348 |
| 116 | Melanoma_Homo sapiens_hsa05218 | 0.60824928 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.60285281 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59520936 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.59133702 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59125299 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.58941556 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58338004 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58057912 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56727906 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50506654 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50132584 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47101197 |
| 128 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46518945 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46418272 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46248223 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43767305 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43334527 |

